Sara Bonstein - Jun 11, 2025 Form 4 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Kevin Brennan, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Jun 11, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 04:36 PM
Previous filing
Jun 12, 2025
Next filing
Jun 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bonstein Sara Director 828 WINTER STREET, SUITE 300, WALTHAM /s/ Kevin Brennan, Attorney-in-Fact 2025-06-12 0001604019

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +31K $0.00 31K Jun 11, 2025 Common Stock 31K $0.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 11, 2025 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 11, 2026 and (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Remarks:

Exhibit 24 - Power of Attorney